Monroid takes the helm at Euro&s Metamax

Share this article:

Euro RSCG Life announced it has hired Cline, Davis & Mann's Julie Monroid to head its MetaMax unit (as first reported in the MM&M Agency Issue, July 2007), which is responsible for much of its Sanofi-Aventis business.

Monroid, who was SVP, group managing director at CDM, becomes EVP, managing director of MetaMax, reporting to MetaMax president and North American co-CEO Doug Burcin. At CDM, she led sizable accounts on Pfizer's Viagra and Relpax and Novo Nordisk's Levemir, NovoLog Mix 70/30, NovoLog and FlexPen -- experience sure to come in handy on Sanofi-Aventis' diabetes drugs Lantus and Lovenox, for which MetaMax handles professional advertising.

Euro RSCG Life reorganized its senior leadership in the spring, following the retirement of chairman Ron Pantello and the departure of CEO Jim Metropoulos, who left just several months after the HAVAS network hired him away from Sudler & Hennessey.

Share this article:

Email Newsletters

More in News

House bill would speed approval once EU OKs same product

House bill would speed approval once EU OKs ...

The Speeding Access to Already Approved Pharmaceuticals Act of 2014 would require FDA to expedite the review of pharmaceuticals that are already approved by the European Union

Rep access continues to shrink

Rep access continues to shrink

Sales reps are experiencing even more limited physician access, according to a report by Chicago consultancy ZS Associates.

Allergan touts reorg, plans to lay off 13% of workforce

Allergan touts reorg, plans to lay off 13% ...

Allergan's second-quarter earnings, and a new round of cuts, are now part of the Botox maker's record as it seeks to remain independent.